ATEM manages Health Square Fund with an evergreen structure, which is considered to be a natural evolution in the Life Sciences investment space — favorable to limited partners and entrepreneurs alike. This modern approach is central to superior compounding returns, maximum value, flexibility and transparency to wealth providers as well as continuous support to healthcare entrepreneurs.
Fundamental factors are fueling steady growth of the healthcare markets worldwide despite any financial vulnerabilities, with latest years setting a new sustainable record.
Rapid population increase in developing countries as well as aging and chronic diseases in the developed world are fundamentally supporting decades’ long growth of the global demand for healthcare
Government and people’s spend on healthcare is constantly increasing both in absolute and relative terms despite financial vulnerabilities, thus creating stable multibillion markets and attractive investment opportunities
2014 continued the row of successful years for biotech IPOs setting a new record since a decade
M&A markets continue to be strong with healthcare companies increasingly driving their revenue growth through acquisitions
Superior drug or technology with strong IP protection targeting vast reimbursed and out-of-pocket markets becomes a must-have asset for larger industry players and yields healthy returns to investors
Early-stage breakthrough science managed by high-caliber serial entrepreneurs with unmatched track-record of success
Late-stage assets backed by healthcare specialists with human proof of concept and blockbuster potential
Growth funding and “Last Money In” investments to support final approval steps, launch and international marketing efforts
The ATEM word (from Old English “æþm”, Greek “asthma”, German “Atem”) stands for “breath” and “spirit” – part and parcel of human life. Our investment strategy is strictly patient-centric and based on the notion that critical change to life creates distinct value. We are laser-focused on life-saving, life-changing and pregnancy-related technologies, viable and relevant to many in the observable future.
Therapies with cure ambition, novel mechanisms of action and delivery as well as human data and signs of efficacy. New generation diagnostics technologies
Therapies and technologies which can save lives with strong human data and manageable regulatory path
New efficient therapies and technologies at all stages, which cure, overcome resistance, shrink time to cure or prevent the disease altogether
Therapies that let people enjoy their life experiences, with human proof-of-concept, understood mechanism of action and clear regulatory path
WOMEN'S HEALTH
Wide range of therapies and technologies at all stages, which help women give birth to healthy childrenWe are diligently monitoring over 30,000 biotech and pharma development projects worldwide via numerous professional databases and our proprietary sources and in-house Big Data instruments. We have exceptional visibility into the following universes:
Our mission is straightforward – we provide efficient access to one of the most exciting and private asset class of Life Sciences innovations with previously unattainable combination of professionalism, accessibility and transparency
We believe that our innovative evergreen investment model is complimentary to the traditional VC funds and benefits wealth providers with shorter investment horizons and stricter requirements to control and costs
FOR LARGER INVESTORS:
FOR LARGER INVESTORS:
We trust the entrepreneurs and the teams we support on both personal and professional levels and seek to become ideal investor/co-investor and strengthen our long-standing relations
We understand and support your focus on your business and your core activities. We would be happy to advise you on Emerging Market strategies where we have an edge, but would not require you to pursue those
We value your time as much as we value ours and provide early feedback to you straight at the first meeting and communicate the probability of investment within few weeks after we get access to your data
Our evergreen structure enables us to support you through the relevant value creation cycle. We do not have vintage or cross-funding issues and work well in a mix with traditional funds for value protection
Our international team combines big picture perspective and long-term technology view with decades of experience in investment, science, operations, IP & legal and portfolio risk management. it comprises high-caliber entrepreneurs, VC veterans & seasoned industry professionals